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ABSTRACT 
Background: Reversible focal lesions in the splenium of the corpus callosum (SCC) or reversible splenial lesion 
syndrome are rare and little is known about their pathophysiology.  
Case summary: The authors describe a case of a 65-year-old female who presented with fever, abnormal behaviour 
and mild hypernatremia. She was on neuropsychiatric treatment for bipolar disorder but denied any history of seizure. 
After an extensive workout to exclude infection, a clinical diagnosis of neuroleptic malignant syndrome (NMS) was 
made. Initial magnetic resonance imaging (MRI) of the brain showed a lesion in the SCC characterized by high-signal 
intensity on T2-weighted and FLAIR sequences with reduced signal intensity on T1-weighted sequence. Diffuse 
weighted imaging (DWI) showed restricted diffusion. There was no enhancement following Gadolinium administration. 
The follow-up MRI 8 weeks later showed complete resolution of the SCC lesion. 
Conclusion: While the pathophysiology of reversible SCC lesions is still unclear, this case highlights the need to 
consider NMS in the differential diagnosis of reversible splenial lesion of the corpus callosum. © 2009 Biomedical 
Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Reversible focal lesions in the splenium of the 
corpus callosum (SCC) or reversible splenial lesion 
syndrome are rare and have only been described in recent 
years. It has been reported in a few cases of mild 
encephalitis and encephalopathy caused by various 
infective agents and has also been reported in less than 
40 epilepsy patients on antiepileptic treatment. The 
underlying pathophysiology of these lesions still remains 
unclear and to this date, various postulations have been 
put forward as the probable cause. The authors present a 
case of this rare finding in a patient with NMS who was 
on neuropsychiatric treatment for bipolar disorder.  
 
 * Corresponding author. Present address: Radiology Department,
Faculty of Medicine, Universiti Kebangsaan Malaysia, Jalan Yaacob
Latif, Bandar Tun Razak, Cheras 56000, Kuala Lumpur, Malaysia.  
Tel: +603-9145 6211; Fax: +603-9173 7307;  
E-mail: sobri_muda@yahoo.com (Ahmad Sobri Muda). 
Available online at http://www.biij.org/2009/4/e24
doi: 10.2349/biij.5.4.e24 
 
 
 
   
(a) 
 
(b) 
 
   
(c) (d) 
Figure 1  MRI imaging of the brain on admission with (a) axial T2-weighted, (b) axial FLAIR, (c) axial DWI and 
(d) corresponding ADC map. An ovoid lesion is seen at the centre of the splenium of the corpus 
callosum, hyperintense on T2 and FLAIR with markedly restricted diffusion and decreased ADC values. 
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Figure 2  Follow up MR imaging performed 8 weeks after discharge with (a) axial FLAIR, (b) sagittal T2-
weighted and (c) axial ADC map showing complete resolution of the SCC lesion and normalization of 
ADC values. 
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CASE REPORT 
A 32-year-old woman presented with a 1-week 
history of fever, abnormal behaviour and refusal to eat 
and talk. She was a known case of bipolar disorder and 
was on multiple neuropsychiatric drugs: clomazapine 10 
mg daily, lithium carbonate 300 mg (morning dose) and 
600 mg (nocturnal dose), lorazepam 1 mg bd and 1.5 mg 
nocturnal dose prn and benzhexol 4 mg tds. On 
examination, she was conscious, flushed and able to 
open eyes spontaneously. Her pupils were equally 
reactive. There was no neck stiffness. Motor examination 
showed increased tone and brisk reflexes, more on the 
left side while the power was reduced to 3/5 in the upper 
limbs. She also had tremors on the right side. Plantar 
reflexes presented bilaterally. 
Laboratory investigation showed leucocytosis with 
predominant neutrophilia and normal platelet and 
hemoglobin counts. Liver function test showed mild 
elevation of the alanine transaminase and alkaline 
phosphatase. Renal profile showed raised sodium level 
(161 mmol/l). Creatine phosphokinase (CPK) was 
markedly raised (537 U/l). Lumbar puncture was done 
and the opening pressure was raised (35 cm H2O). 
Cerebrospinal fluid examination did not show any 
presence of white cells. Ziehl-Nielsen stain, Gram stain 
and Indian ink stain were all negative. The levels of 
glucose and proteins were within normal limits. 
Hemophilus influenza B,  Streptococcus pneumoniae, 
Neisseria meningitides or Streptococcus group B 
antigens were not detected in the cerebrospinal fluid. 
CT scan of the brain showed a slightly swollen and 
hypodense splenium of the corpus callosum. Subsequent 
brain MRI showed swollen splenium of corpus callosum 
and appeared hypointense on T1-weighted image, 
hyperintense on T2-weighted image and FLAIR. 
Restriction in diffusion was observed in the DWI with 
decreased ADC values (Figure 1). No enhancement was 
noted on post-following gadolinium.  
Her CPK level showed an up-going trend from the 
time of admission. It reached the maximum level of 1213 
U/l on the 4
th day of admission and correspondingly, she 
was noted to be more aggressive verbally. She was 
empirically treated for possible CNS infection with 
intravenous ceftriaxone 1 g twice daily and C-Penicillin 
2 megaunit 6-hourly. She was also put on a rehydration 
regime in view of the rising CPK levels and 
hypernatremia. 
Her temperature returned to normal and both CPK 
and sodium levels came down to 417 U/l and 156 mmol/l, 
respectively. Upon discharge, there was only minimal 
cog-wheel rigidity. She was otherwise well and able to 
talk and eat as usual. A follow-up MRI done 8 weeks 
after discharge showed complete resolution of the 
splenial lesion (Figure 2). In view of the clinical history 
and presentation as well as the laboratory findings, a 
clinical diagnosis of neuroleptic malignant syndrome 
was made. 
DISCUSSION 
Reversible splenial lesion of the corpus callosum 
has only been described in recent years and has been 
reported in only a few patients to date. The majority of 
reported cases have been found in patients with epilepsy 
undergoing antiepileptic treatment [1-4]. In these cases, 
different pathophysiologic hypotheses have been put 
forward as the possible etiology and among them are the 
transient effects of anti-epileptic drugs on arginine-
vasopressin and its function in fluid balance systems in a 
condition of vitamin deficiency [1], reversible 
demyelination related to anti-epileptic drug toxicity [2] 
and transient focal oedema due to transcallosal seizure 
spread in secondary generalized seizures [3]. 
Another recently described clinicoradiological 
syndrome is the finding of a solitary reversible SCC 
lesion associated with mild encephalitis or 
encephalopathy [5-7]. Various causative agents have 
been attributed to this findings including influenza A, 
mumps virus, adenovirus, rotavirus, varicella-zoster 
virus,  Escherichia coli, measles and Salmonella 
enteritidis.  
In both these groups, the consistent finding is the 
similar signal characteristics of the SCC lesions on MRI. 
All lesions demonstrate hypointense signal on T1 and 
hyperintense signal on T2 and FLAIR sequences. 
Restricted diffusion was also seen in all cases that 
underwent DWI sequence. None of these lesions showed 
enhancement following gadolinium administration and 
complete resolution of the SCC lesion was seen in all 
patients on follow-up MRI. 
In the group of patients with 
encephalitis/encephalopathy, complete resolution was 
seen on repeat imaging performed three days to two 
months following the abnormal study, regardless of the 
different causative agent. All reported cases had a mild 
clinical course with complete recovery seen within a 
month after onset of neurological symptoms. None of the 
patients developed permanent neurological sequelae. 
In the patient described in this case report, both 
seizures and encephalitis were excluded. Thorough blood 
and cerebrospinal fluid examinations were also negative 
for encephalitis/encephalopathy. The diagnosis of NMS 
was made based on the positive history of 
neuropychiatric treatment as well as the clinical 
presentation and laboratory findings.  
NMS is a relatively rare but potentially fatal side 
effect of antipsychotic medications, which was first 
described by Delay et al in 1960 during early trials of 
haloperidol. The incidence of NMS ranges between 
0.02% to 3.23% of psychiatric patients receiving 
neuropsychiatric treatment. Clinically, it is characterized 
by an abnormal mental status, hyperthermia, ‘lead-pipe’ 
rigidity, akinesia or dystonia, autonomic instability, 
rhabdomyolysis, myoclonus, coarse tremors and 
cogwheeling. Common laboratory findings of NMS 
include increased CPK due to rhabdomyolysis, 
leukocytosis and myoglobinuria [8-12]. Some of these 
features were present in this patient and the authors 
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believe this could be the cause for the reversible splenial 
lesion on MRI.  
Another possibility that needs to be considered in 
this patient is hypernatremia. Maeda M et al reported a 
case of reversible splenial lesion in a patient with 
hypernatremia [13]. However, in this patient, there were 
also additional parenchymal lesions located 
symmetrically in the temporo-occipital lobes, which 
were not reversible and became more extensive in the 
follow-up MRI. This patient eventually developed 
osmotic myelinolysis and had a poor outcome. Although 
the clinical outcome in this patient was more favourable 
and there were no additional parenchymal lesions on 
MRI, hypernatremia as the cause for the reversible 
splenial lesion could not be entirely excluded.  
The underlying pathophysiology of NMS is still 
poorly understood but it is thought to be caused by 
central and peripheral dopaminergic blockade that results 
in muscle rigidity, core temperature elevation and 
hypermetabolism. Virtually all classes of drugs that 
block the D2-receptors have been associated with NMS 
and it was found to be more frequent in patients 
receiving increasing and newly introduced doses of 
neuroleptic medication, medications given via 
intramuscular route, patients requiring physical restraints, 
patients suffering from mental disorders or retardation 
and those receiving a higher total dose of treatment [12]. 
Other risk factors include poor oral intake, dehydration, 
exhaustion, agitation and elevated temperature. 
There are no specific neuroimaging features 
associated with NMS. CT Scan and MRI are usually 
done in patients with NMS to exclude other structural 
lesions or infections that may give rise to similar clinical 
presentation. Abnormalities in the corpus callosum have 
been reported in a patient with neuropsychiatric lupus 
with psychosis [14]. However, in this particular case, the 
patient also has history of seizures. The authors also 
concluded that the location of the lesion in the SCC 
associated with pure psychotic disorders raises the 
possibility that such a lesion may be sufficient to produce 
acute behavioral changes and psychotic features in 
certain patients. 
To date, there has not been any reported case of 
reversible lesion of the SCC that is associated with NMS. 
Establishing a hypothesis for the precise etiology of the 
SCC lesion in this patient is difficult. The authors 
postulate that the lesion itself may be associated with the 
acute behavioral changes found in this patient. They also 
highlight the possibility of including NMS as one of the 
differential diagnosis of reversible splenial lesion of the 
corpus callosum. 
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